See All Slides - tctmd.com

Slides

Presentation TCT 2013

TCT-10. Differences Between US and non-US Cohorts after PCI and Dual Antiplatelet Therapy: Patient Characteristics, Randomization

Presenter: Laura Mauri

October 29, 2013

Presentation TCT 2013

How and When Do I Assess a Jailed Side Branch After Provisional Stenting?

Presenter: Bon-Kwon Koo

October 29, 2013

Presentation TCT 2013

Case Presentation and Topic Review: Why Does This Patient Have Outflow Tract Obstruction?

Presenter: Mark Sherrid

October 29, 2013

Presentation TCT 2013

Position Statement: Given the Advances in Stent Technology, Pharmacology, Imaging and Technique, All the Prior PCI vs. CABG Trials Are Archaic and Obsolete!

Presenter: Dean Kereiakes

October 29, 2013

Presentation TCT 2013

Twelve-Month Clinical Outcomes from the Optimal Duration of Dual Antiplatelet Therapy Following Treatment with Endeavor (Zotarolimus-Eluting Stent) in Real-World Japanese Patients with Coronary Artery

Presenter: Masato Nakamura

October 29, 2013

Presentation TCT 2013

Why I Believe CABG Is (Usually) Better for My Patients

Presenter: Joseph Sabik

October 29, 2013

Presentation TCT 2013

Early Vascular Restoration following treatment of single de-novo coronary artery lesions with the DESolve Nx Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) at 6 months: Insights...

Presenter: J. Ribamar Costa Jr.

October 29, 2013

Presentation TCT 2013

My Most Valuable TAVR Lessons: An Interventionalist's Perspective

Presenter: Stephan Windecker

October 29, 2013

Presentation TCT 2013

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

Presenter: Vivek Reddy

October 29, 2013

Presentation TCT 2013

TCT-75. Novel Fully-Quantitative Virtual Histology Analysis of Confluent Necrotic Core Size and Fibrous Cap Thickness in Relation to Conventional Phenotypic Plaque Type Assessme...

Presenter: Piotr Musialek

October 29, 2013

Advertisement

Slides

TCT-10. Differences Between US and non-US Cohorts after PCI and Dual Antiplatelet Therapy: Patient Characteristics, Randomization

How and When Do I Assess a Jailed Side Branch After Provisional Stenting?

Case Presentation and Topic Review: Why Does This Patient Have Outflow Tract Obstruction?

Position Statement: Given the Advances in Stent Technology, Pharmacology, Imaging and Technique, All the Prior PCI vs. CABG Trials Are Archaic and Obsolete!

Twelve-Month Clinical Outcomes from the Optimal Duration of Dual Antiplatelet Therapy Following Treatment with Endeavor (Zotarolimus-Eluting Stent) in Real-World Japanese Patients with Coronary Artery

Why I Believe CABG Is (Usually) Better for My Patients

Early Vascular Restoration following treatment of single de-novo coronary artery lesions with the DESolve Nx Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) at 6 months: Insights...

My Most Valuable TAVR Lessons: An Interventionalist's Perspective

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

TCT-75. Novel Fully-Quantitative Virtual Histology Analysis of Confluent Necrotic Core Size and Fibrous Cap Thickness in Relation to Conventional Phenotypic Plaque Type Assessme...

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content